Pharmaceuticals

Emphysema Treatment Market Forecast With Insights On Demand And Industry Growth

April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Emphysema Treatment Market Expected To Scale Between 2026 And 2030?

The emphysema treatment market has observed strong expansion over recent years. It is anticipated to grow from $5.4 billion in 2025 to $5.8 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. The increase witnessed in the historic period is attributed to factors such as the increasing prevalence of COPD, a growing smoking population, limited awareness of early diagnosis, the widespread adoption of traditional inhalation therapies, and the rising hospital infrastructure in developing regions.

The emphysema treatment market size is anticipated to experience substantial growth over the next few years, projected to reach $7.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period is driven by advancements in gene therapy, the increasing adoption of digital health solutions, the growth of home healthcare services, the development of portable oxygen devices, and a rising demand for minimally invasive surgeries. Significant trends expected in the forecast period include personalized treatment plans, the emergence of home-based care solutions, a focus on minimally invasive therapies, the expansion of telehealth and remote monitoring, and the implementation of advanced pulmonary rehabilitation programs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What Primary Drivers Are Shaping The Emphysema Treatment Market?

The increasing incidence of chronic obstructive pulmonary disease (COPD) is anticipated to fuel the expansion of the emphysema treatment market moving forward. COPD, or chronic obstructive pulmonary disease, encompasses a group of conditions, such as emphysema and chronic bronchitis, which lead to obstructed airflow and respiratory issues. Treatments for emphysema are crucial for mitigating the progression of COPD, as their primary objectives involve managing symptoms, re-establishing lung function, and slowing down the disease’s development. As an illustration, a research study published by JAMA Network Open, a medical journal affiliated with the American Medical Association, indicated in December 2023 that the global prevalence of chronic obstructive pulmonary disease (COPD) cases could nearly hit 600 million by 2050 globally, representing a 23% rise in its occurrence. Consequently, the escalating prevalence of chronic obstructive pulmonary disease (COPD) cases is a key driver for the emphysema treatment market.

What Segment Categories Shape The Emphysema Treatment Market Segment Landscape?

The emphysema treatment market covered in this report is segmented –

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments

2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies

3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:

1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs

2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics

3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers

4) By Leukotriene Modifiers: Montelukast, Zafirlukast

5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems

6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines

7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides

8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation

9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

What Trends Are Affecting The Direction Of The Emphysema Treatment Market?

Leading companies within the emphysema market are developing innovative products like inhalation aerosols to achieve a competitive advantage. Inhalation aerosols are pharmaceutical preparations delivered as a fine mist or spray of liquid medicine suspended in a propellant or a blend of propellants. For example, in July 2023, Viatris Inc., a US-based pharmaceutical firm, in partnership with Kindeva Drug Delivery L.P., a US-based pharmaceutical CDMO, introduced Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This launch represents the first FDA-approved generic alternative to AstraZeneca’s Symbicort for individuals managing asthma, chronic obstructive pulmonary disease (COPD), and emphysema. This drug-device combination product, offered in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths, signifies a vital step forward in offering accessible and economical treatment choices for those with respiratory difficulties. Breyna is intended for the maintenance treatment of airflow obstruction, to decrease exacerbations in COPD patients, and to manage asthma symptoms in patients aged six years and older, including those with emphysema.

Who Are The Companies Operating Across The Emphysema Treatment Market Value Chain?

Major companies operating in the emphysema treatment market are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc.

Get The Full Emphysema Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Which Region Dominates The Emphysema Treatment Market By Market Share?

North America was the largest region in the emphysema treatment market in 2025. The regions covered in the emphysema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Emphysema Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Browse Through More Reports Similar to the Global Emphysema Treatment Market 2026, By The Business Research Company

Emphysema Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Anaphylaxis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

Bronchitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/bronchitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795